Omaha, NE, United States of America

Zhenshan Jia

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenshan Jia. Retrieved from https://idiyas.com/inventor/zhenshan-jia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Zhenshan Jia: Innovator in Drug Delivery Systems

Introduction

Zhenshan Jia is a prominent inventor based in Omaha, NE (US), known for his significant contributions to the field of drug delivery systems. With a total of 5 patents to his name, he has made remarkable strides in developing innovative therapeutic solutions.

Latest Patents

One of his latest patents is titled "Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform." This application discloses a prodrug-based thermosensitive gel, referred to as 'ProGel,' which is comprised of conjugates of dmg molecules with water-soluble polymeric carriers. These carriers are capable of controlled release of the dmg molecules into the tissue of a subject. The patent also discusses the use of ProGel-drug conjugates for the treatment of various diseases or disorders, along with methods of preparing them. Another significant patent is "Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof." This patent reveals polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and their use for treating diseases and disorders. Specifically, it highlights PEG-conjugated dexamethasone compounds and methods for treating inflammatory and autoimmune diseases, including lupus.

Career Highlights

Zhenshan Jia is affiliated with the Board of Regents of the University of Nebraska, where he continues to advance his research and innovation in drug delivery systems. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Zhenshan has collaborated with notable colleagues, including Dong Wang and Xiaobei Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhenshan Jia's work exemplifies the spirit of innovation in the field of drug delivery systems. His patents reflect a commitment to improving therapeutic options for patients, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…